Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Aquestive Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 54 | 48 | −6 |
| Shares | 19.1M | 22.9M | +3.77M (+19.8%) |
| Value | $31.5M | $21.5M | −$9.97M (−31.7%) |
New holders (6)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CI Private Wealth, LLC | 457,326 | $699.7K | 0.00% |
| Heron Bay Capital Management | 14,025 | $21.5K | 0.01% |
| Barclays PLC | 7,144 | $10.9K | 0.00% |
| Lazard Asset Management LLC | 766 | $1.00K | 0.00% |
| Qube Research & Technologies Ltd | 6 | $9 | 0.00% |
| BNP Paribas Arbitrage, SA | 1 | $2 | 0.00% |
Sold out (12)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Hillsdale Investment Management Inc. | 66,600 | $109.9K |
| Goldman Sachs Group Inc | 57,149 | $94.3K |
| Two Sigma Securities, LLC | 21,937 | $36.2K |
| Schonfeld Strategic Advisors LLC | 16,900 | $27.9K |
| Kestra Private Wealth Services, LLC | 16,732 | $27.6K |
| Cubist Systematic Strategies, LLC | 12,196 | $20.1K |
| Royal Bank of Canada | 4,000 | $7.00K |
| Simplex Trading, LLC | 2,502 | $4.00K |
| Advisor Group Holdings, Inc. | 2,000 | $3.30K |
| Group One Trading, L.P. | 783 | $1.29K |
| NewSquare Capital LLC | 130 | $215 |
| FMR LLC | 25 | $41 |